全球更年期潮热市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

全球更年期潮热市场需求预计将从 2023 年的 411.7 亿美元达到近 657.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.34%。

潮热是更年期併发症最常见的血管舒缩症状。一般症状包括突然感到强烈的温暖感遍布全身并持续几分钟，导致出汗、潮红和心悸。这可能发生在白天或晚上。潮热的强度因女性而异，取决于许多生理化学因素。它可能是轻度、中度、重度和使人衰弱的。荷尔蒙替代疗法被认为是治疗更年期潮热的黄金标准。然而，长期荷尔蒙替代疗法会增加乳癌的风险以及与年龄增长相关的风险，例如中风、血栓和其他健康相关问题。其他疗法包括服用维生素 E 补充剂和抗忧郁药物以及许多补充疗法。在美国和其他已开发地区，大约70%的更年期女性患有可持续数年的潮热症状。

市场动态

推动该市场成长的重要因素是更年期症状治疗的需求不断增长，因为女性在此期间会经历精神和身体的变化。此外，失眠、烦躁、情绪波动、疲劳、焦虑、偏头痛、排蚁和潮热等症状的显着增加也推动了对更年期症状药物的需求。除了药物治疗外，知名人士还建议女性采用尖端技术设备，例如具有个人恆温器的类似智慧手錶的设备。然而，解决更年期潮热问题的重要认知行为疗法也推动了市场的成长。对非药物治疗的需求不断增长预计将推动此类疗法在全球更年期潮热市场的成长。然而，女性对更年期潮热的认识不断提高，将进一步推动预测期内全球更年期潮热市场的成长。除口服药物外，许多治疗方案的出现也促进了全球更年期潮热市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球更年期潮热市场的各个细分市场进行了包容性评估。更年期潮热产业的成长和趋势为本研究提供了整体方法。

市场区隔

更年期潮热市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按治疗类型

• 荷尔蒙治疗
• 非荷尔蒙治疗
• 替代治疗

按配销通路

• 医院药房
• 零售药局
• 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲更年期潮热市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。更年期潮热市场的主要参与者包括辉瑞公司、诺华公司、诺和诺德、艾尔建公司、梯瓦製药工业有限公司、Mylan NV、久光製药有限公司、默克公司、葛兰素史克公司，TherapeuticsMD Inc. 本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：更年期潮热 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按治疗类型进行的市场吸引力分析
  • 按配销通路分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球更年期潮热市场分析：依治疗类型

• 按治疗类型概述
• 按治疗类型进行历史和预测数据分析
• 荷尔蒙治疗
• 非荷尔蒙治疗
• 替代治疗

第 6 章：全球更年期潮热市场分析：按分销管道

• 配销通路概述
• 按配销通路进行历史和预测资料分析
• 医院药房
• 零售药局
• 网路药局

第 7 章：全球更年期潮热市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：更年期潮热公司的竞争格局

• 更年期潮热市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Pfizer Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Novartis AG
• 公司概况
• 公司收入
• 产品
• 最新动态
• Novo Nordisk A/S
• 公司概况
• 公司收入
• 产品
• 最新动态
• Allergan Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Teva Pharmaceutical Industries Ltd
• 公司概况
• 公司收入
• 产品
• 最新动态
• Mylan NV
• 公司概况
• 公司收入
• 产品
• 最新动态
• Hisamitsu Pharmaceutical Co. Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merck & Co. Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• GlaxoSmithKline Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• TherapeuticsMD Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

The global demand for Menopausal Hot Flashes Market is presumed to reach the market size of nearly USD 65.75 Billion by 2032 from USD 41.17 Billion in 2023 with a CAGR of 5.34% under the study period 2024-2032.

Hot flashes are the most usual vasomotor symptom of menopause complications. The general symptoms include a sudden sensation of intense warmth spreading over the body and lasting for several minutes, leading to sweat, red flush, and palpitations. This may occur during the day or at night. The intensity of hot flashes varies from woman to woman depending on many physiochemical factors. It may be mild, moderate, and severe, and debilitating. Hormone replacement therapy has been considered the gold standard for treating menopausal hot flashes. However, long-term HRT has an increased risk of breast cancer and risk associated with increasing age, such as stroke, blood clots, and other health-related problems. Other therapies include intake of vitamin E supplements and anti-depressants along with many complementary therapies. In the U.S. and other developed regions, about 70% of menopausal women suffer from hot flashes that can last for several years.

MARKET DYNAMICS

The significant factor driving the growth of this market is the rising need of treatment for menopause symptoms as women go through mental and physical changes during this. In addition, a significant spike in insomnia, irritability, mood swings, fatigue, anxiety, migraine, formication, and hot flashes also propels the demand for menopause symptom medication. Apart from medication, the prominent players are counseling women to adopt edge-cutting technological devices such as smartwatch-like devices which have a personal thermostat. However, a significant cognitive behavior therapies to address the menopausal hot flash issues also drives the growth of the market. The growing demand for non-pharmacological treatment is expected to propel the growth of such therapies in the global menopausal hot flashes market. However, the increasing awareness among women regarding menopausal hot flashes will further drive the global menopausal hot flashes market's growth during the forecast period. The availability of many treatment options other than oral medications has also boosted the growth of the global menopausal hot flashes market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Menopausal Hot Flashes. The growth and trends of Menopausal Hot Flashes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Menopausal Hot Flashes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

• Hormonal Treatment
• Non-hormonal Treatment
• Alternative Treatment

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Menopausal Hot Flashes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Menopausal Hot Flashes market include Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan Plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline Plc, TherapeuticsMD Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. MENOPAUSAL HOT FLASHES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Treatment Type
  • 3.7.2 Market Attractiveness Analysis By Distribution Channel
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY TREATMENT TYPE

• 5.1. Overview By Treatment Type
• 5.2. Historical and Forecast Data Analysis By Treatment Type
• 5.3. Hormonal Treatment Historic and Forecast Sales By Regions
• 5.4. Non-hormonal Treatment Historic and Forecast Sales By Regions
• 5.5. Alternative Treatment Historic and Forecast Sales By Regions

6. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 6.1. Overview By Distribution Channel
• 6.2. Historical and Forecast Data Analysis By Distribution Channel
• 6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 6.4. Retail Pharmacies Historic and Forecast Sales By Regions
• 6.5. Online Pharmacies Historic and Forecast Sales By Regions

7. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MENOPAUSAL HOT FLASHES COMPANIES

• 8.1. Menopausal Hot Flashes Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF MENOPAUSAL HOT FLASHES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Pfizer Inc.
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Novartis AG
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Novo Nordisk A/S
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Allergan Plc
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Teva Pharmaceutical Industries Ltd
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Mylan N.V.
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Hisamitsu Pharmaceutical Co. Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Merck & Co. Inc.
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. GlaxoSmithKline Plc
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. TherapeuticsMD Inc
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Treatment Type (Units and USD MN)
• Hormonal Treatment Market Sales By Geography (Units and USD MN)
• Non-hormonal Treatment Market Sales By Geography (Units and USD MN)
• Alternative Treatment Market Sales By Geography (Units and USD MN)
• Analysis By Distribution Channel (Units and USD MN)
• Hospital Pharmacies Market Sales By Geography (Units and USD MN)
• Retail Pharmacies Market Sales By Geography (Units and USD MN)
• Online Pharmacies Market Sales By Geography (Units and USD MN)
• Global Menopausal Hot Flashes Market Sales By Geography (Units and USD MN)
• North America Market Analysis (Units and USD MN)
• United States Market Analysis (Units and USD MN)
• Canada Market Analysis (Units and USD MN)
• Mexico Market Analysis (Units and USD MN)
• Europe Market Analysis (Units and USD MN)
• Europe Market Estimate By Country (Units and USD MN)
• United Kingdom Market Analysis (Units and USD MN)
• France Market Analysis (Units and USD MN)
• Germany Market Analysis (Units and USD MN)
• Italy Market Analysis (Units and USD MN)
• Russia Market Analysis (Units and USD MN)
• Spain Market Analysis (Units and USD MN)
• Rest of Europe Market Analysis (Units and USD MN)
• Asia Pacific Market Analysis (Units and USD MN)
• China Market Analysis (Units and USD MN)
• Japan Market Analysis (Units and USD MN)
• India Market Analysis (Units and USD MN)
• South Korea Market Analysis (Units and USD MN)
• Australia Market Analysis (Units and USD MN)
• South East Asia Market Analysis (Units and USD MN)
• Rest of Asia Pacific Market Analysis (Units and USD MN)
• Latin America Market Analysis (Units and USD MN)
• Brazil Market Analysis (Units and USD MN)
• Argentina Market Analysis (Units and USD MN)
• Peru Market Analysis (Units and USD MN)
• Chile Market Analysis (Units and USD MN)
• Rest of Latin America Market Analysis (Units and USD MN)
• Middle East & Africa Market Analysis (Units and USD MN)
• Saudi Arabia Market Analysis (Units and USD MN)
• UAE Market Analysis (Units and USD MN)
• Israel Market Analysis (Units and USD MN)
• South Africa Market Analysis (Units and USD MN)
• Rest of Middle East and Africa Market Analysis (Units and USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Menopausal Hot Flashes Report
• Market Research Process
• Market Research Methodology
• Global Menopausal Hot Flashes Market Size, By Region (Units and USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Treatment Type
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Treatment Type (Units and USD MN)
• Hormonal Treatment Market Sales By Geography (Units and USD MN)
• Non-hormonal Treatment Market Sales By Geography (Units and USD MN)
• Alternative Treatment Market Sales By Geography (Units and USD MN)
• Global Market Analysis By Distribution Channel (Units and USD MN)
• Hospital Pharmacies Market Sales By Geography (Units and USD MN)
• Retail Pharmacies Market Sales By Geography (Units and USD MN)
• Online Pharmacies Market Sales By Geography (Units and USD MN)
• Global Market Sales (Units and USD MN)
• North America Market Sales (Units and USD MN)
• Europe Market Sales (Units and USD MN)
• Asia Pacific Market Sales (Units and USD MN)
• Latin America Market Sales (Units and USD MN)
• Middle East & Africa Market Sales (Units and USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.